biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Sniper007on Jul 09, 2013 11:53pm

107 Views

Post# 21597985

RE:RE:RE:This is bananas!

I would say you chose your handle truthfully GlassHalfEmpty.

If you've been paying attention to BTI for the last two years and you're making statements like that, your brain is HalfEmpty. You're in the state of blaming others but really, have you already forgotten the Feb. 7, 2013 results? Absolutely amazing results and JD had nothing to do with it!!! If you had any brains you would at least think your glass is HalfFull with BTI. Yeah, the share price sux right now for shareholders, no question, but it's a beautiful buying opportunity too if you have any disposible income. With the impending news right on our doorstep too, how can you pass up the opportunity?

Sniper

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario